Has Mark Lee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $173,421 in general payments to Mark Lee, MD across 882 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Lee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Lee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Lee, MD

Clinical Cardiac Electrophysiology · Long Beach, CANPI 1487943510

Payments from drug & device makers

$173,421in general payments, 2019–2025

Across 882 payments — averaging $196.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$70K
Eli Lilly$48K
Medical Device Business Services, Inc.$17K
Abbott$10K
Medtronic$9K
Wilson Cook Medical Incorporated$4K
plus $16K from 51 others

$26,233in research payments, 2019–2025

Across 2 payments — averaging $13,116 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$26K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	90	$70,280
Eli Lilly	12	$47,540
Medical Device Business Services, Inc.	19	$16,829
Abbott	51	$9,958
Medtronic(2 entities)	134	$9,109
Wilson Cook Medical Incorporated	2	$3,600
Boston Scientific	78	$2,722
Johnson & Johnson	75	$1,473
Atricure, Inc.	13	$1,380
Novartis	75	$1,377
Cook Incorporated	4	$914
Pfizer	43	$835
Sanofi-aventis U.S. LLC	34	$767
AstraZeneca	29	$622
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	27	$604
E.r. Squibb & Sons, L.L.C.	32	$531
Amgen	24	$507
Inari Medical, Inc.	1	$375
Boehringer Ingelheim	13	$342
Cardiva Medical, Inc.	14	$341
Merck	15	$322
Kestra Medical Technology Services, Inc.	9	$320
Astellas Pharma US Inc	2	$198
Impulse Dynamics (USA) Inc.	6	$196
Philips North America LLC	5	$193
Actelion Pharmaceuticals US, Inc.	7	$154
Kiniksa Pharmaceuticals, Ltd.	6	$144
Regeneron Healthcare Solutions, Inc.	7	$140
Altathera Pharmaceuticals LLC	2	$136
W. L. Gore & Associates, Inc.	6	$131
Biotronik Inc.	3	$125
Stryker	1	$111
Esperion Therapeutics, Inc.	4	$93
Amarin Pharma, Inc.	4	$90
Abiomed	2	$90
Cook Medical LLC	3	$89
Acutus Medical, Inc.	1	$73
Lantheus Medical Imaging, Inc.	3	$70
Heartflow, Inc.	3	$66
Merz North America, Inc.	1	$56
Lexicon Pharmaceuticals, Inc.	2	$55
Arbor Pharmaceuticals, Inc.	3	$50
Bayer	2	$43
Cardiofocus, Inc.	1	$36
Corindus Inc.	1	$36
Novo Nordisk	2	$36
Kiniksa Pharmaceuticals International, PLC	1	$32
Baxter Healthcare	1	$30
Inspire Medical Systems, Inc.	1	$28
Alnylam Pharmaceuticals Inc.	1	$28
Irhythm Technologies, Inc.	1	$23
Cvrx, Inc.	1	$23
Biom'up France SAS	1	$22
Scpharmaceuticals Inc.	1	$22
Smith+Nephew	1	$19
Kowa Pharmaceuticals America, Inc.	1	$18
Bardy Diagnostics, Inc.	1	$15

How this compares

$173,421 in reported general payments places this provider in the 75th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$668,274

Medicare patients

650

Services billed

4,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical cardiac electrophysiology in Long Beach

David KrummenSan Diego$7.3M
Jonathan DukesVentura$2.9M
Shephal DoshiSanta Monica$2.9M
Arash AryanaSacramento$2.4M
Marco PerezStanford$2.1M
Rahul DoshiLos Angeles$2M
Mayer RashtianPasadena$1.8M
Rajesh BankerNewport Beach$1.6M
Edward GerstenfeldSan Francisco$1.5M
Jonathan HsuSan Diego$1.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →